Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
153.40
+2.26 (1.50%)
At close: Apr 14, 2026, 4:00 PM EDT
152.45
-0.95 (-0.62%)
After-hours: Apr 14, 2026, 7:13 PM EDT
Insmed Analyst Ratings
Total Analysts
24
Consensus Rating
Strong Buy
Price Target
$201.17
Upside
+31.14%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $212 → $216 | Buy | Maintains | $212 → $216 | +40.81% | Apr 14, 2026 |
| Barclays | Barclays | Buy Maintains $231 → $237 | Buy | Maintains | $231 → $237 | +54.50% | Apr 1, 2026 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $166 → $212 | Hold → Buy | Upgrades | $166 → $212 | +38.20% | Mar 30, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $230 → $245 | Strong Buy | Maintains | $230 → $245 | +59.71% | Mar 26, 2026 |
| Mizuho | Mizuho | Buy Maintains $204 → $206 | Buy | Maintains | $204 → $206 | +34.29% | Mar 25, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $210 → $215 | Buy | Maintains | $210 → $215 | +40.16% | Mar 24, 2026 |
| Stifel | Stifel | Strong Buy Maintains $205 → $208 | Strong Buy | Maintains | $205 → $208 | +35.59% | Mar 24, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $175 → $177 | Buy | Maintains | $175 → $177 | +15.38% | Mar 24, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $211 → $213 | Strong Buy | Maintains | $211 → $213 | +38.85% | Mar 24, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $208 → $175 | Buy | Maintains | $208 → $175 | +14.08% | Mar 23, 2026 |
| Jefferies | Jefferies | Strong Buy Initiates $228 | Strong Buy | Initiates | $228 | +48.63% | Mar 16, 2026 |
| Mizuho | Mizuho | Buy Maintains $211 → $204 | Buy | Maintains | $211 → $204 | +32.99% | Feb 24, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $230 | Strong Buy | Reiterates | $230 | +49.93% | Feb 23, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $234 → $208 | Buy | Maintains | $234 → $208 | +35.59% | Feb 20, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $157 → $162 | Hold | Maintains | $157 → $162 | +5.61% | Jan 30, 2026 |
| Barclays | Barclays | Buy Initiates $231 | Buy | Initiates | $231 | +50.59% | Jan 28, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.